Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, SARS-CoV-2 and COVID-19 Research, and COVID-19 Clinical Research Studies.
Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screening.
ARF4-mediated intracellular transport as a broad-spectrum antiviral target.
Author Correction: ARF4-mediated intracellular transport as a broad-spectrum antiviral target.
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses.
The infection kinetics and transmission potential of two Guaico Culex viruses in Culex quinquefasciatus mosquitoes.
Targeting ARF4-mediated intracellular transport as broad-spectrum antivirals
A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity
PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor.
A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity.
Oral administration of D-glucosamine confers broad-spectrum protection against human coronaviruses including SARS-CoV-2.
Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants.
GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia
GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia.
Treatment of SARS-CoV-2-induced pneumonia with NAD<sup>+</sup> and NMN in two mouse models.
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters.
TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation
The m6A methylome of SARS-CoV-2 in host cells
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2.
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
SARS-CoV-2 infection in the mouse olfactory system.
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates.
Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein.
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry.
Structure and function analysis of a potent human neutralizing antibody CA521<sup>FALA</sup> against SARS-CoV-2.
Proteome-wide epitope mapping identifies a resource of antibodies for SARS-CoV-2 detection and neutralization.
Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants.
hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants.
GP73 is a glucogenic hormone that contributes to SARS-CoV-2-induced hyperglycemia
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors